hesperidin methyl chalcone

2-propen-1-one, 1-[4-[[6-O-(6-deoxy-a-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2-hydroxy-6-methoxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)-, (2E)-

CAS: 24292-52-2 C29 H36 O15 MW: 624.59392000

Identification

Namehesperidin methyl chalcone
CAS Number24292-52-2
EINECS246-128-2
FDA UNII4T2GVA922X
Molecular FormulaC29 H36 O15
Molecular Weight624.59392000
MDL NumberMFCD00010438

Regulatory

Physical Properties

Assay 95.00 to 100.00
Food Chemicals Codex Listed No
Boiling Point 952.97 °C. @ 760.00 mm Hg (est)
Flash Point 589.00 °F. TCC ( 309.50 °C. ) (est)
logP (o/w) 0.267 (est)
Soluble in water, 692.9 mg/L @ 25 °C (est)

Cosmetic Information

CosIngcosmetic data
Cosmetic Usesantioxidants

No sensory data available

Safety Information

Preferred SDSView
Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categoryantioxidants
Recommendation for hesperidin methyl chalcone usage levels up tonot for fragrance use.
Recommendation for hesperidin methyl chalcone flavor usage levels up tonot for flavor use.

BOC Sciences

Best of Chemicals Supplier

Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...

View All Website 1-631-485-4226 account@bocsci.com

Potential Uses

None Found

Natural Occurrence

not found in nature

Synonyms

hesperidin methylchalcone 3- hydroxy-4-[(2E)-3-(3-hydroxy-4-methoxyphenyl)-2-propenoyl]-5-methoxyphenyl 6-O-(6-deoxy-a-L-mannopyranosyl)-β-D-glucopyranoside 2- propen-1-one, 1-[4-[[6-O-(6-deoxy-a-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-2-hydroxy-6-methoxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)-, (2E)- PubMed: Quality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study). PubMed: Assessment of quality of life in Mexican patients suffering from chronic venous disorder - impact of oral Ruscus aculeatus-hesperidin-methyl-chalcone-ascorbic acid treatment - 'QUALITY Study'. PubMed: Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency. PubMed: An open-label, randomized multicenter study comparing the efficacy and safety of Cyclo 3 Fort versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency. PubMed: An open-label, randomised multicentre study comparing the efficacy and safety of CYCLO 3 FORT versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency. PubMed: Treatment of secondary lymphedema of the upper limb with CYCLO 3 FORT. PubMed: A thin-layer chromatographic-fluorometric method for quantitative analysis of hesperidin methyl chalcone in parmaceuticals. PubMed: Effect of hesperidin-methyl-chalcone on capillary resistance in the internal organs of the guinea pig and the rat. PubMed: The effect of hesperidin methyl chalcone on the nervous control of the nictitating membrane. PubMed: Effect of hesperidin methyl chalcone, vitamin P, on diabetic retinopathy. PubMed: Administration of massive doses of vitamin P hesperidin methyl chalcone.